Muscle Strength and Functional Autonomy of Elderly Women
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
This study shows an evaluation of the correlation between the muscle strength levels and functional autonomy of elderly women.
Condition or disease
Muscle, Ligament and Fascia Disorders
The aim of this study was to evaluate the correlation between the muscle strength levels and functional autonomy of elderly women with impaired muscle-skeletal system depending on the normal IGF-1 level. The target-population was composed by elderly women aged between 60 and 75 years (age: 67.79 ± 5.11 years, BMI: 28.01 ± 5.4), residents of an asylum, with IGF-1 levels within the normal values for the age (normo-IGF-1). Evaluations of the muscle strength (1-RM test) and the functional autonomy (GDLAM Protocol) in the performance of activities of daily living (ADL), and a measurement of basal serum levels of IGF-1 (Chemiluminescence method) were performed.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study:
60 Years to 75 Years (Adult, Older Adult)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
The population consists of 123 elderly women residents of São Lucas shelter, located in Cacimba Velha, Teresina-PI, Brazil. The sample consists of 35 elderly women. The elderly participants in the study signed a written informed consent.
present a muscle-skeletal dysfunction, such as osteoporosis, arthritis, tendinitis, but being able to perform their ADL without help from others;
did not practice physical activity for at least 12 months;
provide a normal IGF-1 level for their age;
elderly women unfit to perform the strength and functional autonomy tests for the medical assessment;